X

Vous n'êtes pas connecté

Rubriques :

  - DESANG.NET - A la Une - 14/Jul 07:24

Coaching boosts GLP-1 effectiveness in managing weight loss

One promising way to promote drug adherence and lifestyle change is to provide health well-being coaching (HWC) alongside GLP-1 prescriptions. When adhered to, glucagon-like peptide 1 receptor agonist (GLP-1) prescriptions are a highly effective treatment for obesity, with clinical trials showing GLP-1 treatment inducing weight losses of 10%-25% over a 1-2-year period. However, GLP-1s do […]

Articles similaires

Sorry! Image not available at this time

Certain Factors May Predict Weight Fluctuations After GLP-1 Receptor Agonist Treatment

drugs.com - 15/Jul 15:07

TUESDAY, July 15, 2025 -- For adults with overweight or obesity, certain factors might influence weight loss after taking glucagon-like peptide 1...

Sorry! Image not available at this time

GLP-1 Receptor Agonists May Improve Outcomes in Idiopathic Intracranial Hypertension

drugs.com - 21/Jul 14:07

MONDAY, July 21, 2025 -- For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment...

Sorry! Image not available at this time

GLP-1 Receptor Agonists May Improve Outcomes in Idiopathic Intracranial Hypertension

drugs.com - 21/Jul 14:07

MONDAY, July 21, 2025 -- For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment...

Sorry! Image not available at this time

New study identifies factors linked to successful weight loss using GLP-1RAs

news.medical.net - 09/Jul 14:06

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss after taking prescription...

Sorry! Image not available at this time

GLP-1 Receptor Agonist Use in T2D Tied to Increased Risk for GERD, GERD Complications

drugs.com - 17/Jul 15:07

THURSDAY, July 17, 2025 -- For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with an increased...

Sorry! Image not available at this time

Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity

drugs.com - 15:07

TUESDAY, July 22, 2025 -- For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a...

Sorry! Image not available at this time

Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity

drugs.com - 15:07

TUESDAY, July 22, 2025 -- For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a...

Sorry! Image not available at this time

Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM

drugs.com - 21/Jul 21:07

MONDAY, July 21, 2025 -- For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using...

Sorry! Image not available at this time

Menopause Hormone Therapy Boosts GLP-1 Drug Effectiveness, Researchers Say

drugs.com - 14/Jul 10:15

MONDAY, July 14, 2025 — Good news for women of a certain age: Hormone replacement therapy for menopause appears to boost the effectiveness of GLP-1...

Sorry! Image not available at this time

Corteria Pharmaceuticals initiates Phase 2 trial in heart failure and Phase 1 trial in obesity with its first-in-class CRF2 agonists

wn.com - 21/Jul 11:32

CRAFT-WHF Phase 2 trial of COR-1167 initiated in patients with worsening heart failure Phase 1 trial of COR-1389 ongoing in subjects with obesity ...

Les derniers communiqués